Cart
sales@molnova.com
7,4-Dihydroxyhomoisoflavanone
CAS No. 1178893-64-5
7,4-Dihydroxyhomoisoflavanone( —— )
Catalog No. M31309 CAS No. 1178893-64-5
(3R)-7,4’-Dihydrohomoisoflavanone, a natural compound, exhibits potent antibacterial properties against both S. aureus and methicillin-resistant Staphylococcus aureus (MRSA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 603 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name7,4-Dihydroxyhomoisoflavanone
-
NoteResearch use only, not for human use.
-
Brief Description(3R)-7,4’-Dihydrohomoisoflavanone, a natural compound, exhibits potent antibacterial properties against both S. aureus and methicillin-resistant Staphylococcus aureus (MRSA).
-
Description(3R)-7,4’-Dihydrohomoisoflavanone, a natural compound, exhibits potent antibacterial properties against both S. aureus and methicillin-resistant Staphylococcus aureus (MRSA).
-
In Vitro(3R)-7,4’-Dihydrohomoisoflavanone shows cytotoxicity against K-562, SMMC-7721, and SGC-7901 cell lines with IC50 values of 15.6 μg/mL, 30.2 μg/mL, and 20.5 μg/mL, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1178893-64-5
-
Formula Weight270.3
-
Molecular FormulaC16H14O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(2R,3S,11bS)-Dihydro...
(2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder.
-
RGX-104 free Acid
RGX-104 free Acid is an agonist of potent liver-X nuclear hormone receptor (LXR)?.
-
Letolizumab
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.
